Canagliflozin is transforming care for diabetic kidney disease by reducing kidney failure risk by 30%. Learn how this SGLT2 inhibitor protects kidneys, who benefits most, and what to expect.
Health Information (62)
Health & Nutrition (9)
Health & Wellness (3)
Health (1)
Science & Technology (1)
November 2025 (11)
October 2025 (28)
September 2025 (15)
August 2025 (6)
July 2025 (21)